Description: Esophagus cancer with esophagus tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

Description: Esophagus tissue and esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BN02014

Description: GI (esophagus, stomach, liver, small intestine, colon and rectum) carcinoma with normal tissue array, including pathology grade, TNM and clinical stage (stromal tumor reference AJCC 8th), 48 cases/96 cores, replacing GI961a

Description: Esophagus tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl₂, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Description: Esophagus cancer, cancer adjacent and normal esophagus tissue array, including squamous cell carcinoma,adenocarcinoma,undifferentiated carcinoma, AT and normal tissue, pathology grade, TNM and clinical stage (AJCC 8.0), 104 cases/104 cores (core size 1.5mm), replacing ES1021

Description: Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing BC02012

Description: Different stages of esophagus cancer with esophagus tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores

Description: Esophagus cancer with matched cancer adjacent esophagus tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 51 cases/102 cores (1.5 mm).

Description: Esophagus tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl₂, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

Description: Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores

Description: Human esophagus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human esophagus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated esophagus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated esophagus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Description: Esophagus squamous cell carcinoma with normal adjacent esophagus tissue array, including pathology grade and TNM/Stage, 45 cases/90 cores (core size 1.5mm), replacing ES902

Description: Digestive system (esophagus, stomach, colon, rectum, liver, pancreas) cancer with matched adjacent normal tissue array, including TNM, pathology grade and clinical stage, 72 cases/144 cores, replaced by GI1441a

Description: Digestive system (esophagus, stomach, colon, rectum, liver, pancreas) cancer with matched adjacent normal tissue array, including TNM, pathology grade and clinical stage, 35 cases/70 cores, replacing GI701

Description: Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 60 cases/120 cores, replacing ES1201

Description: Esophagus squamous cell carcinoma with matched adjacent nomal esophagus tissue array, including TNM and pathology grade, 96 cases/ 192 cores (core size 1.0mm)

Description: Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue array, inclduing pathology grade, TNM and clinical stage (reference AJCC 7th version), 6 cases/24 cores, replacing ES241

Description: Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores

Description: Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 16 cases/78 cores, replacing BC02111

Description: Mouse Esophagus Tissue Lysate

Description: Human Esophagus Tissue Lysate

Description: Human esophagus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human esophagus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated esophagus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated esophagus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Description: Esophagus cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases with grading and TNM staging data) tissues.

Description: Esophagus cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data.

Description: Human esophagus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human esophagus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the esophagus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The esophagus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Human esophagus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human esophagus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the esophagus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The esophagus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

Description: Esophagus carcer test tissue array, with normal esophagus tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Description: Human Esophagus Tumor Tissue Lysate

Description: A Rabbit polyclonal antibody against Human Normal Mucosa Of Esophagus Specific 1 (NMES1)

Description: Human Diabetes Esophagus Tissue Lysate

Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Description: Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores (core size 1.5mm), replaced by ES1505a

Description: Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores (core size 1.5mm), replacing ES1505

Description: Human Esophagus Lysate Membrane Fraction

Description: A Rabbit polyclonal antibody against Human Normal Mucosa Of Esophagus Specific 1 (NMES1). This antibody is labeled with PE.

Description: Esophagus cancer and normal tissue array, with grade and stage data, 40 cases/80 cores

Description: Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases/80 cores

Description: Esophagus cancer and normal tissue array, inclduing pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T021b

Description: Esophagus cancer with normal tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T022c

Description: A Rabbit polyclonal antibody against Human Normal Mucosa Of Esophagus Specific 1 (NMES1). This antibody is labeled with APC.

Description: A Rabbit polyclonal antibody against Human Normal Mucosa Of Esophagus Specific 1 (NMES1). This antibody is labeled with Cy3.

Description: A Rabbit polyclonal antibody against Human Normal Mucosa Of Esophagus Specific 1 (NMES1). This antibody is labeled with FITC.

Description: A Rabbit polyclonal antibody against Human Normal Mucosa Of Esophagus Specific 1 (NMES1). This antibody is labeled with HRP.

Description: Innovative Grade US Origin Bovine Esophagus

Description: Innovative Grade US Origin Bovine Esophagus

Description: Innovative Grade US Origin Bovine Esophagus

Description: Innovative Grade US Origin Bovine Esophagus

Description: Innovative Grade US Origin Bovine Esophagus

Description: Innovative Grade US Origin Bovine Esophagus

Description: Innovative Grade US Origin Bovine Esophagus

Description: Innovative Grade US Origin Bovine Esophagus

Description: Innovative Grade US Origin Bovine Esophagus